Literature DB >> 15053039

Factors associated or related to with pathological severity of nonalcoholic fatty liver disease.

Kyung Sik Park1, Yeong Seok Lee, Heo Won Park, Sang Hyuck Seo, Byung Guk Jang, Jun Young Hwang, Kwang Bum Cho, Jae Seok Hwang, Sung Hoon Ahn, Yu Na Kang, Gap Chul Kim.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has been more and more often regarded as a serious disorder, because nonalcoholic steatohepatitis (NASH), a part of NAFLD, may progress to the end stage of liver disease. Though an advanced age, obesity, diabetes mellitus (DM) etc. being not infrequent conditions in Korea, are known to exacerbate the severity of this disease, there are only a few Korean reports on this subject. The purpose of this study is to identify possible factors that might add up to the pathological severity of this disorder in Korean patients.
METHODS: Of 60 patients with steatosis found at liver biopsy, 43 NAFLD patients were reviewed retrospectively after exclusion of other liver diseases.
RESULTS: The cases of steatosis were mild, moderate, and severe in 9. 10, and 24 patients, respectively. The degree of necroinflammatory activity was mild, moderate, and severe in 33, 9, and 1 patients, respectively. There were no established factors directly related to these classes. As to fibrosis, the cases were classified as none, mild, moderate, severe, and cirrhotic in 9, 11, 16, 7, and 0 patients, respectively. The stage of fibrosis correlated with the age (p < 0.001), BMI (body mass index) (p = 0.032), and the platelet count (p = 0.009), but the presence of NASH was associated only with BMI (p = 0.002) and obesity (p = 0.001).
CONCLUSION: It seems that there are no factors that are directly related to the degree of steatosis or necroinflammatory activity. BMI seems to be a unique factor directly related to both the severity of fibrosis and the presence of NASH. The age and the platelet count are factors that are directly related to the degree of fibrosis but not to the presence of NASH.

Entities:  

Mesh:

Year:  2004        PMID: 15053039      PMCID: PMC4531555          DOI: 10.3904/kjim.2004.19.1.19

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  26 in total

1.  Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.

Authors:  A Sonsuz; M Basaranoglu; G Ozbay
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

4.  Relationship of aminotransferases to liver histological status in chronic hepatitis C.

Authors:  M M Haber; A B West; A D Haber; A Reuben
Journal:  Am J Gastroenterol       Date:  1995-08       Impact factor: 10.864

5.  Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.

Authors:  T Kawasaki; A Takeshita; K Souda; Y Kobayashi; M Kikuyama; F Suzuki; F Kageyama; Y Sasada; E Shimizu; G Murohisa; S Koide; T Yoshimi; H Nakamura; R Ohno
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.

Authors:  J C Luo; S J Hwang; C R Lai; C L Lu; C P Li; S H Tsay; J C Wu; F Y Chang; S D Lee
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

8.  Chronic hepatitis B virus infection. Viral replication and patterns of inflammatory activity: serological, clinical and histological correlations.

Authors:  M O Paz; F Brenes; P Karayiannis; T P Jowett; P J Scheuer; H C Thomas
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  9 in total

1.  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Kento Imajo; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

2.  Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?

Authors:  James H Tabibian; Mariana Lazo; Francisco A Durazo; Hsin-Chieh Yeh; Myron J Tong; Jeanne M Clark
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

3.  Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients.

Authors:  Adrian T Billeter; Sarah Wloka; Rouven Behnisch; Thomas Albrecht; Stephanie Roessler; Benjamin Goeppert; Sebastian Mueller; Felix Nickel; Beat Müller
Journal:  Obes Facts       Date:  2021-08-20       Impact factor: 3.942

4.  Risk factors of cryptogenic hepatocellular carcinoma in patients with low body mass index or without metabolic syndrome.

Authors:  Hwa Young Song; Hyo Keun Lee; June Sung Lee; Jong Yeon Kim; Yun Hyuk Yim; Tae Jun Song; Won Ki Bae; Nam-Hoon Kim; Kyung-Ah Kim
Journal:  Korean J Intern Med       Date:  2012-02-28       Impact factor: 2.884

5.  NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.

Authors:  Mazen Noureddin; Aarshi Vipani; Catherine Bresee; Tsuyoshi Todo; Irene K Kim; Naim Alkhouri; Veronica Wendy Setiawan; Tram Tran; Walid S Ayoub; Shelly C Lu; Andrew S Klein; Vinay Sundaram; Nicholas N Nissen
Journal:  Am J Gastroenterol       Date:  2018-06-08       Impact factor: 12.045

6.  Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

Authors:  Thierry Poynard; Vlad Ratziu; Frederic Charlotte; Djamila Messous; Mona Munteanu; Françoise Imbert-Bismut; Julien Massard; Luninita Bonyhay; Mohamed Tahiri; Dominique Thabut; Jean François Cadranel; Brigitte Le Bail; Victor de Ledinghen
Journal:  BMC Gastroenterol       Date:  2006-11-10       Impact factor: 3.067

7.  Association between platelet count as a noninvasive marker and ultrasonographic grading in patients with nonalcoholic Fatty liver disease.

Authors:  Afagh Garjani; Abdolrasoul Safaeiyan; Manouchehr Khoshbaten
Journal:  Hepat Mon       Date:  2015-01-18       Impact factor: 0.660

8.  Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.

Authors:  Monika Ciupińska-Kajor; Marek Hartleb; Maciej Kajor; Michał Kukla; Mariusz Wyleżoł; Dariusz Lange; Lukasz Liszka
Journal:  Hepatol Int       Date:  2011-11-29       Impact factor: 6.047

Review 9.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.